Adocia will be presenting two abstracts at the 79th Scientific Sessions of the American Diabetes Association® ADA2019.
Join us on June 9th and June 10th for these presentations in San Francisco – USA!
Details of the accepted abstracts are presented below:
- Oral Presentation #150-OR: Biochaperone Pramlintide Insulin (BCPramIns), A New Co-formulation Of Pramlintide (pram) And Human Insulin (ins), Improves Post-prandial Blood Glucose (BG) Versus Both Separate Injections Of Pram+Ins And Insulin Lispro (lis) in Subjects With T1D
Presenting Author: Dr. Grégory Meiffren
Session: Innovations in Insulin Therapy
Date and Time: Sunday, June 09 at 9:30 AM PST
Location: Room S-303 (South, Level 3)
- Poster #2008-P: BioChaperone Glucagon Exenatide (BC Glu Exe), a Stable Combination of Glucagon (Glu) and Exenatide (Exe) Achieved Larger Body Weight (BW) Loss than Exe Alone in DIO Mice
Presenting Author: Dr. Martin Gaudier
Session: 22-A Obesity-Animal
Date and Time: Monday, June 10 at 12:00 PM – 1:00 PM PST
Location: Poster Hall
Place: Moscone Center, San Francisco, CA, USA